+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human breast cancer tissue using P09019(ZFP2 Antibody) at dilution 1/40. (Original magnification: ×200)    

  
  

The ZFP2 antibody is designed to target ZFP2. a member of the zinc finger protein (ZFP) family, which plays roles in transcriptional regulation and chromatin remodeling. Zinc finger proteins typically contain conserved zinc-binding domains that facilitate DNA, RNA, or protein interactions. ZFP2. also known as ZNF2 or ZNF538 in some contexts, is implicated in developmental processes and cellular differentiation. While its exact biological functions remain under investigation, ZFP2 is hypothesized to regulate gene expression through epigenetic modifications or direct DNA binding, potentially influencing stem cell pluripotency or tissue-specific gene programs.

Antibodies against ZFP2 are valuable tools for studying its expression patterns, subcellular localization, and interactions in various biological contexts. They are commonly used in techniques like Western blotting, immunofluorescence, and chromatin immunoprecipitation (ChIP) to elucidate ZFP2's role in health and disease. Research has explored its involvement in cancer, neurodevelopment, and reproductive biology, though mechanistic insights are still emerging. Commercial ZFP2 antibodies are often raised in rabbits or mice using recombinant protein fragments or synthetic peptides, with validation steps confirming specificity. As interest in zinc finger proteins grows due to their therapeutic potential, ZFP2 antibodies contribute to decoding its functional relevance in gene regulatory networks and disease pathways.